Dyadic International (DYAI) Treasury Shares (2017 - 2026)
Dyadic International (DYAI) posted Treasury Shares of $18.9 million for Q1 2026, little changed sequentially from $18.9 million in Q4 2025, and little changed YoY from $18.9 million in Q1 2025.
Dyadic International (DYAI) Treasury Shares (2017 - 2026) Analysis & Trends
Dyadic International has reported Treasury Shares for 10 years, with the latest figure at $18.9 million in Q1 2026.
- Quarterly Treasury Shares changed 0.16% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (changed 0.16% YoY) and the FY2025 annual result came in at $18.9 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $18.9 million in Q1 2026 per DYAI's latest filing, from $18.9 million in the prior quarter.
- Over five years, Treasury Shares peaked at $12.3 million in Q1 2022 and troughed at -$12.3 million in Q4 2022.
- A 5-year average of $3803.3 and a median of $64656.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares surged 100058.28% in 2022, then slumped 99.9% in 2023.
- Over 5 years, Treasury Shares stood at $18.9 million in 2022, then changed by 0.0% to $18.9 million in 2023, then changed by 0.0% to $18.9 million in 2024, then changed by 0.0% to $18.9 million in 2025, then changed by 0.0% to $18.9 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $18.9 million, $18.9 million, and $18.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | -12.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.25 Mn |
| Mar 31, 2026 | 12.25 Mn |
| Mar 31, 2026 | 18.93 Mn |
| Mar 31, 2026 | 18.93 Mn |
| Dec 31, 2025 | 64,656.00 |
| Dec 31, 2025 | 18.93 Mn |
| Dec 31, 2025 | 18.93 Mn |
| Dec 31, 2025 | 64,656.00 |
| Sep 30, 2025 | 18.90 Mn |
| Sep 30, 2025 | 12.25 Mn |
| Sep 30, 2025 | 12.25 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | -12.25 Mn |
| Jun 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | -12.25 Mn |
| Mar 31, 2025 | 18.90 Mn |
| Mar 31, 2025 | -12.25 Mn |
| Mar 31, 2025 | -12.25 Mn |
| Mar 31, 2025 | 18.90 Mn |